Clinical Trial Update: Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating effects of vorinostat and HXTC on persistent HIV-1 infection in patients on ART has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HXTC
• Vorinostat (vorinostat)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2023-05-12